Sulfatrim and Platelet count increased - a phase IV clinical study of FDA data

Summary:

Platelet count increased is reported as a side effect among people who take Sulfatrim (sulfamethoxazole; trimethoprim), especially for people who are female, 60+ old, also take Metformin, and have Vasculitis.

The phase IV clinical study analyzes which people have Platelet count increased when taking Sulfatrim. It is created by eHealthMe based on reports of 4,093 people who have side effects when taking Sulfatrim from the FDA, and is updated regularly.

What is Sulfatrim?

Sulfatrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 4,140 Sulfatrim users. Check the latest studies of Sulfatrim.

What is Platelet count increased?

Platelet count increased is found to be associated with 958 drugs and 1,190 conditions by eHealthMe. Check the latest studies of Platelet count increased.

On Jul, 19, 2026

4,093 people reported to have side effects when taking Sulfatrim.
Among them, 12 people (0.29%) have Platelet count increased.

Could Sulfatrim cause Platelet count increased?

Among these 12 people:

What is the gender of people who have Platelet count increased when taking Sulfatrim? *

female: 100 %
male: 0.0 %

What is the age of people who have Platelet count increased when taking Sulfatrim? *

What are other drugs people take besides Sulfatrim? *

What are other side effects people have besides Platelet count increased? *

Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 9 people, 75.00%
C-Reactive Protein Increased: 9 people, 75.00%
Haematocrit Decreased: 9 people, 75.00%
Haemoglobin Decreased: 9 people, 75.00%
Red Cell Distribution Width Increased: 9 people, 75.00%
Mean Cell Haemoglobin Decreased (less than normal haemoglobin per red blood cell in a sample of blood): 9 people, 75.00%
Wound Secretion: 6 people, 50.00%
Cardiac Disorder: 6 people, 50.00%
Lung Disorder (lung disease): 6 people, 50.00%
Mean Cell Haemoglobin Concentration Decreased (less concentration of haemoglobin in a given volume of packed red blood cells): 6 people, 50.00%

What are the existing conditions these people have? *

Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 25.00%
Asthma: 2 people, 16.67%
Combined Immunodeficiency: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfatrim and have Platelet count increased?

- Check whether Platelet count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulfatrim:

Sulfatrim (4,140 reports)

Platelet count increased treatments and more:

Platelet count increased (18,565 reports)

How severe was Platelet count increased and when was it recovered:

Platelet count increased in Sulfatrim

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Platelet count increased and drugs with ingredients of sulfamethoxazole; trimethoprim

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sulfatrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet count increased:

Platelet count increased (958 drugs)

Browse all the conditions that are associated with Platelet count increased:

Platelet count increased (1,190 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Sulfatrim) and Sulfatrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.